Condition

Metastatic Uveal Melanoma in the Liver clinical trials and research

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Adding IL-2 to tebentafusp to overcome resistance in uveal melanoma

  This trial tests whether giving interleukin‑2 (IL‑2) together with tebentafusp can help people with HLA‑A*02:01 metastatic uveal melanoma who progressed on tebentafusp.

  Recruiting Phase 1/2 St Vincent's Hospital, Sydney · Sydney, New South Wales and 1 other locations · NCT07063875

• Combining Tebentafusp with Radioembolization for Liver Metastases from Uveal Melanoma

  This study is testing whether combining a new drug called Tebentafusp with a specific type of radiation treatment can help people with liver cancer that started from uveal melanoma.

  Recruiting Phase 2 University of Miami · Miami, Florida · NCT06627244

Related topics

Quick answers

How many Metastatic Uveal Melanoma in the Liver clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Australia (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →